Jumadilova Z[au] - Search Results

Year	Number of Results
2005	6
2006	1
2007	2
2008	2
2009	4
2010	2
2011	1
2012	3
2013	1
2016	1
2021	1
2022	0

1

Long-term amikacin liposome inhalation suspension in cystic fibrosis patients with chronic P. aeruginosa infection.

Bilton D, Fajac I, Pressler T, Clancy JP, Sands D, Minic P, Cipolli M, Galeva I, Solé A, Quittner AL, Jumadilova Z, Ciesielska M, Konstan MW; CLEAR-110 Study Group. Bilton D, et al. Among authors: jumadilova z. J Cyst Fibros. 2021 Nov;20(6):1010-1017. doi: 10.1016/j.jcf.2021.05.013. Epub 2021 Jun 16. J Cyst Fibros. 2021. PMID: 34144923 Free PMC article. Clinical Trial.

2

A Pragmatic Randomized Trial Comparing Telephone-Based Enhanced Pharmacy Care and Usual Care to Support Smoking Cessation.

Gong J, Baker CL, Zou KH, Bruno M, Jumadilova Z, Lawrence D, Wilson B, Ewel C. Gong J, et al. Among authors: jumadilova z. J Manag Care Spec Pharm. 2016 Dec;22(12):1417-1425. doi: 10.18553/jmcp.2016.22.12.1417. J Manag Care Spec Pharm. 2016. PMID: 27882838 Clinical Trial.

3

Predictors of discontinuing overactive bladder medications.

Brubaker L, Fanning K, Goldberg EL, Benner JS, Trocio JN, Bavendam T, Jumadilova Z. Brubaker L, et al. Among authors: jumadilova z. BJU Int. 2010 May;105(9):1283-90. doi: 10.1111/j.1464-410X.2009.09035.x. Epub 2009 Nov 12. BJU Int. 2010. PMID: 19912189

4

Defining urinary urgency: patient descriptions of "gotta go".

Coyne KS, Harding G, Jumadilova Z, Weiss JP. Coyne KS, et al. Among authors: jumadilova z. Neurourol Urodyn. 2012 Apr;31(4):455-9. doi: 10.1002/nau.21242. Epub 2012 Jan 24. Neurourol Urodyn. 2012. PMID: 22275170

5

Patient-reported reasons for discontinuing overactive bladder medication.

Benner JS, Nichol MB, Rovner ES, Jumadilova Z, Alvir J, Hussein M, Fanning K, Trocio JN, Brubaker L. Benner JS, et al. Among authors: jumadilova z. BJU Int. 2010 May;105(9):1276-82. doi: 10.1111/j.1464-410X.2009.09036.x. Epub 2009 Nov 12. BJU Int. 2010. PMID: 19912188

6

Meeting the obligation to communicate clinical trial results to study volunteers.

Getz K, Hallinan Z, Simmons D, Brickman MJ, Jumadilova Z, Pauer L, Wilenzick M, Morrison B. Getz K, et al. Among authors: jumadilova z. Expert Rev Clin Pharmacol. 2012 Mar;5(2):149-56. doi: 10.1586/ecp.12.7. Expert Rev Clin Pharmacol. 2012. PMID: 22390557

7

The responsiveness of the OAB-q among OAB patient subgroups.

Coyne KS, Matza LS, Thompson C, Jumadilova Z, Bavendam T. Coyne KS, et al. Among authors: jumadilova z. Neurourol Urodyn. 2007;26(2):196-203. doi: 10.1002/nau.20342. Neurourol Urodyn. 2007. PMID: 17016794 Clinical Trial.

8

Effects of the moderate CYP3A4 inhibitor, fluconazole, on the pharmacokinetics of fesoterodine in healthy subjects.

Malhotra B, Dickins M, Alvey C, Jumadilova Z, Li X, Duczynski G, Gandelman K. Malhotra B, et al. Among authors: jumadilova z. Br J Clin Pharmacol. 2011 Aug;72(2):263-9. doi: 10.1111/j.1365-2125.2011.04007.x. Br J Clin Pharmacol. 2011. PMID: 21545485 Free PMC article. Clinical Trial.

9

Overactive bladder and women's sexual health: what is the impact?

Coyne KS, Margolis MK, Jumadilova Z, Bavendam T, Mueller E, Rogers R. Coyne KS, et al. Among authors: jumadilova z. J Sex Med. 2007 May;4(3):656-666. doi: 10.1111/j.1743-6109.2007.00493.x. J Sex Med. 2007. PMID: 17498103

10

Persistence with overactive bladder pharmacotherapy in a Medicaid population.

Shaya FT, Blume S, Gu A, Zyczynski T, Jumadilova Z. Shaya FT, et al. Among authors: jumadilova z. Am J Manag Care. 2005 Jul;11(4 Suppl):S121-9. Am J Manag Care. 2005. PMID: 16161385 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results